These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 18045192)

  • 21. Oxcarbazepine vs. valproate in the treatment of mood and schizoaffective disorders.
    Raja M; Azzoni A
    Int J Neuropsychopharmacol; 2003 Dec; 6(4):409-14. PubMed ID: 14604456
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cardio-hepatic metabolic derangements and valproic acid.
    Mazzoccoli G; Longhitano C; Vinciguerra M
    Curr Clin Pharmacol; 2014 May; 9(2):165-70. PubMed ID: 23237609
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New generation of valproic acid.
    Trojnar MK; Wierzchowska-Cioch E; Krzyzanowski M; Jargiełło M; Czuczwar SJ
    Pol J Pharmacol; 2004; 56(3):283-8. PubMed ID: 15215557
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of VPA on bone: From clinical studies to cell cultures-The molecular mechanisms revisited.
    Pitetzis DA; Spilioti MG; Yovos JG; Yavropoulou MP
    Seizure; 2017 May; 48():36-43. PubMed ID: 28391043
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Valproic acid for the treatment of pediatric malignant glioma.
    Driever PH; Knüpfer MM; Cinatl J; Wolff JE
    Klin Padiatr; 1999; 211(4):323-8. PubMed ID: 10472571
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and evaluation of antiallodynic and anticonvulsant activity of novel amide and urea derivatives of valproic acid analogues.
    Kaufmann D; Bialer M; Shimshoni JA; Devor M; Yagen B
    J Med Chem; 2009 Nov; 52(22):7236-48. PubMed ID: 19877649
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Valproic Acid-Induced Anxiety and Depression Behaviors are Ameliorated in p39 Cdk5 Activator-Deficient Mice.
    Takahashi M; Takasugi T; Kawakami A; Wei R; Ando K; Ohshima T; Hisanaga SI
    Neurochem Res; 2022 Sep; 47(9):2773-2779. PubMed ID: 35674931
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Valproic acid inhibits the growth of cervical cancer both in vitro and in vivo.
    Sami S; Höti N; Xu HM; Shen Z; Huang X
    J Biochem; 2008 Sep; 144(3):357-62. PubMed ID: 18515856
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Valproic acid-induced parkinsonism in the elderly: a comprehensive review of the literature.
    Mahmoud F; Tampi RR
    Am J Geriatr Pharmacother; 2011 Dec; 9(6):405-12. PubMed ID: 21993183
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Therapeutic effects of add-on low-dose dextromethorphan plus valproic acid in bipolar disorder.
    Chen SL; Lee SY; Chang YH; Chen PS; Lee IH; Wang TY; Chen KC; Yang YK; Hong JS; Lu RB
    Eur Neuropsychopharmacol; 2014 Nov; 24(11):1753-9. PubMed ID: 25262178
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induction of neurotrophic and differentiation factors in neural stem cells by valproic acid.
    Almutawaa W; Kang NH; Pan Y; Niles LP
    Basic Clin Pharmacol Toxicol; 2014 Aug; 115(2):216-21. PubMed ID: 24460582
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Valproic acid: a migraine prophylaxis alternative.
    Shelton CE; Connelly JF
    Ann Pharmacother; 1996; 30(7-8):865-6. PubMed ID: 8826572
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bipolar depression: an overview.
    Oral ET; Vahip S
    IDrugs; 2004 Sep; 7(9):846-50. PubMed ID: 15470602
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of adjunct valproic acid on clinical symptoms and saccadic eye movements in schizophrenia.
    Larrison AL; Babin SL; Xing Y; Patel SS; Wassef AA; Sereno AB
    Hum Psychopharmacol; 2011 Oct; 26(7):517-25. PubMed ID: 22031266
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Valproic Acid for Treatment of Hyperactive or Mixed Delirium: Rationale and Literature Review.
    Sher Y; Miller Cramer AC; Ament A; Lolak S; Maldonado JR
    Psychosomatics; 2015; 56(6):615-25. PubMed ID: 26674479
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacological response in juvenile bipolar disorder subtypes: A naturalistic retrospective examination.
    Masi G; Perugi G; Millepiedi S; Mucci M; Pfanner C; Berloffa S; Pari C; Gagliano A; D'Amico F; Akiskal HS
    Psychiatry Res; 2010 May; 177(1-2):192-8. PubMed ID: 20381170
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel trans-platinum complexes of the histone deacetylase inhibitor valproic acid; synthesis, in vitro cytotoxicity and mutagenicity.
    Griffith DM; Duff B; Suponitsky KY; Kavanagh K; Morgan MP; Egan D; Marmion CJ
    J Inorg Biochem; 2011 Jun; 105(6):793-9. PubMed ID: 21497577
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Paclitaxel plus valproic acid versus paclitaxel alone as second- or third-line therapy for advanced gastric cancer: a randomized Phase II trial.
    Fushida S; Kinoshita J; Kaji M; Oyama K; Hirono Y; Tsukada T; Fujimura T; Ohta T
    Drug Des Devel Ther; 2016; 10():2353-8. PubMed ID: 27524882
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Valproic acid induces apoptosis in chronic lymphocytic leukemia cells through activation of the death receptor pathway and potentiates TRAIL response.
    Lagneaux L; Gillet N; Stamatopoulos B; Delforge A; Dejeneffe M; Massy M; Meuleman N; Kentos A; Martiat P; Willems L; Bron D
    Exp Hematol; 2007 Oct; 35(10):1527-37. PubMed ID: 17697742
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Valproic acid: an old drug newly discovered as inhibitor of histone deacetylases.
    Göttlicher M
    Ann Hematol; 2004; 83 Suppl 1():S91-2. PubMed ID: 15124690
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.